for Oct 11, 2019
‘Managing urinary tract infections’. An article I wrote, published in @med_indonews. An overview of the management approached to UTI’s, highlighting the importance of antimicrobial stewardship. @PriscillaLynch @itcarlow @The_ISHA @PracticeNurses https://t.co/elp8qVCdgN pic.twitter.com/9hOcg5S8Xc
— Theresa Lowry-Lehnen (@lehnent) October 11, 2019
#WhyID! This fun read in OFID is just the thing for your Friday reading as you prepare for your weekend -- a David Letterman-style "Top 10 Reasons" to choose ID. Which one of the 10 is your favorite? Any @BradCutrellMD might have missed? https://t.co/5mQiNX4pLq
— Paul Sax (@PaulSaxMD) October 11, 2019
NEW 🔥in CID @dr_michaelmarks@gpollara
— Antibiotic Steward (@ABsteward) October 11, 2019
Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in OPAT. #IDTwitter #medtwitter #OVIVA https://t.co/oqNI1fLhfT pic.twitter.com/tNHi9qY8Gt
NEW reflections post: cluster RCT on whether to use single rooms to apply contact precautions for ESBL-E carriers; a fairly comprehensive no for E. coli; not sure sure about for Klebsiella https://t.co/m3Nr2XfYQm @TheLancetInfDis Congrats @MarcBonten @avipnl @jankluytmans et al.
— Jon Otter (@jonotter) October 11, 2019
DYK: Most new #antibiotics aren't based on new ways to kill bacteria. They’re actually incremental improvements on existing drugs where resistance is already developing, @bioharmonytrx and @UCSDnews’s David Pride write. https://t.co/iSbIrAPuJd
— Save Antibiotics (@saveantibiotics) October 11, 2019
A Virus in Koala #DNA Shows #evolution in Action.
— Microbes&Infection (@MicrobesInfect) October 11, 2019
Many animals, including humans, have DNA left over from ancient viral infections. In koalas, researchers are studying the process in real time.https://t.co/nhLO2nraNH #retrovirus #KoRV pic.twitter.com/65HBd09y9Y
Register for CIDRAP's live webcast on the Value of Diagnostics in Antimicrobial Stewardship: An Asia-Pacific Outlook! Nov 5th, 2:00 PM (GMT+8:00). Register below 👇 @CIDRAP_ASP https://t.co/u6G06vEPR9 pic.twitter.com/sw60tSUIKx
— CDDEP (@CDDEP) October 11, 2019
World Reports @TheLancet: #AMR in the Middle East: “a perfect storm” https://t.co/Is3q9Hr6qW
— The Lancet Infectious Diseases (@TheLancetInfDis) October 11, 2019
NEW 🔥 @antibioticsmdpi @BiologyAsPoetry
— Antibiotic Steward (@ABsteward) October 11, 2019
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy? #IDtwitter #medtwitter https://t.co/9p8j1iRABi pic.twitter.com/XTkNFWv0Vv
Antibiotic stewardship refers to a set of coordinated strategies to improve the use of antimicrobial medications with the goal of enhancing patient health outcomes, reducing resistance to antibiotics, and decreasing unnecessary costs. Learn more at https://t.co/aTVJq3JQkN
— The Forum (@ForumHSPH) October 11, 2019
.@Ddrekonja & colleagues looked at asymptomatic bacteriuria knowledge within the VA system & identified significant opportunities for education:
— Mike Stevens (@Dr_Mike_Stevens) October 11, 2019
https://t.co/HazZI9zm0i #AntimicrobialStewardship @ICHEJournal @SHEA_Epi @VAStewie
Scientists Found New #antibiotics - Right In the Human #microbiota.
— Microbes&Infection (@MicrobesInfect) October 11, 2019
“The human #microbiome has genes to make countless complex chemicals ... We’re looking at “an unprecedented resource for drug discovery from within the human body.”https://t.co/arjwJdTO8e pic.twitter.com/QrTeJydy7A
Great to see @HSELive https://t.co/SAGiWiajz6 listed on @CIDRAP @CIDRAP_ASP list of educational resources for #antimicrobialstewardship @DrNuala 🇮🇪🇮🇪🇮🇪 Educational Multimedia | CIDRAP https://t.co/fQuvrauZub
— Gerry Hughes (@astghughes) October 11, 2019
Our team @VCUHealth also had a few #AntimicrobialStewardship articles in the September issue; please ☑️ them out if inclined!https://t.co/QnRamKMYgZhttps://t.co/O0IUuhEfgx@ICHEJournal @SHEA_Epi @gonzalobearman @Dr_Dan_Markley @JPierceMD
— Mike Stevens (@Dr_Mike_Stevens) October 11, 2019
Antimicrobial stewardship. Call it ASP. Call it AMS. Just dont https://t.co/PmXDtvguXu AST, I guess 🤷🏼♀️
— Monica Mahoney (@mmPharmD) October 11, 2019
Thanks to all who voted! I will painstakingly try to change my ways. https://t.co/9L3dRDzZNt
Interesting new study: "Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence" https://t.co/0PMh4bkrUw @JAMANetworkOpen #openaccess
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 😷 (@eliowa) October 11, 2019
Obituaries of Stuart Levy, renowned campaigner for prudent use of antibiotics, @TheLancet https://t.co/6GG4sIkVcq and @TheLancetInfDis https://t.co/Dvse7lCvt3 #AMR
— The Lancet Infectious Diseases (@TheLancetInfDis) October 11, 2019
Exploiting time-lapse microfluidic microscopy as a tool for target-drug interaction studies in Mycobacterium #AACJournal https://t.co/bBdEhBwp8Q pic.twitter.com/YzxUsEcAWJ
— ASM (@ASMicrobiology) October 11, 2019
Enjoyed the new @ICHEJournal podcast released this week! Three articles from the September issue were highlighted.
— Mike Stevens (@Dr_Mike_Stevens) October 11, 2019
Podcast available here: https://t.co/rU9citIrph
[also on iTunes]
Sept TOC available here: https://t.co/apcRP4xAO3 @SHEA_Epi
This review of resistant bacterial pathogens in the Middle East region from last year gives additional detail https://t.co/s6JVhkWeWe #AMR
— The Lancet Infectious Diseases (@TheLancetInfDis) October 11, 2019
OFID: Adults with sinus infections were prescribed fewer antibiotics, with care more consistent with guidelines, when seen virtually, via telemedicine, compared to patients seen in person. https://t.co/sOablEPNgo #IDSAJournals @lisaidpharmd @Kayla_Wren216 @kmjohnson_
— IDSA (@IDSAInfo) October 11, 2019
Staphylococcus aureus complex – S. argenteus – bug of the week – Microbiology and Infectious Diseases postgraduate teaching (PRIDA) https://t.co/wVSkNfpxDd
— José Ramón Paño (@joserrapa) October 11, 2019
New faculty news!!
— Walid Gellad (@walidgellad) October 11, 2019
Really thrilled to announce that Katie Suda is joining our @PittGIM, @PittCP3, and @vaequity faculty.
Katie is a pharmacist and pharmacoepi researcher who is studying antimicrobial and opioid stewardship among 🦷.
Welcome @Sudamonas to @PittTweet.
"We're in a tough situation because of the increasing likelihood that each time you or I develop an infection that is resistant, we will have very limited [treatment] options or no options at all,” @CDCGov’s Lauri Hicks said. https://t.co/cmtQVzEGmd @NBCNews
— Save Antibiotics (@saveantibiotics) October 11, 2019
Fantastic presentation on #antimicrobialstewardship in paediatric patients - consider what parents really want #reassurance #safetynetting #HealthierTogether. Also need to think about palatability and practical issues of giving antibiotics. Thank you for sharing @doctorsanjay 🙌🏻 pic.twitter.com/F89OIOMA4X
— Claire Brandish (@ClaireBrandish1) October 11, 2019
This highlights the unintended consequences of viewing the AMR solution as simply just reducing antibiotics. Much more complex***We need to focus on appropriate use of diagnostics AND antibiotics. An urgent need for clinical pathways for complex UTIs https://t.co/kCD8IXbvqx
— NCAS_Australia (@NCAS_Aus) October 11, 2019
I recommend the Nov 2019 issue of Sexual Health dedicated to gonorrhea and how to tackle this global epidemic in the era of drug resistance. The articles are here: https://t.co/l0soSE3Cvj
— Carlos del Rio (@CarlosdelRio7) October 11, 2019
Enough already! “There is no reporting for other medical procedures, other than reporting for infectious diseases to control outbreaks," Blue told VICE. “This is nothing more than an attempt to infringe on women’s choice.” https://t.co/kp14cOIaCk
— Grandmothers for Reproductive Rights (@GRRNow) October 11, 2019
#WhyID: Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter | Open Forum Infectious Diseases | Oxford Academic Excellent article! Need to build up our ID workforce. #IDtwitter @CMC_IM https://t.co/cCeI8Lc8RM
— michael leonard (@mkleona) October 11, 2019
STEWARDSHIP / RESISTANCE SCAN: #Probiotics and #Cdiff risk; MCR genes on Algerian farms https://t.co/CgSm13ujZh #AMR #MCR1 #AntibioticStewardship
— CIDRAP (@CIDRAP) October 11, 2019
'A Lego-like approach to improve nature's own ability to kill dangerous bacteria' #StopSuperbugs https://t.co/H5YQJ0N36x via @rpinews @EurekAlert
— Antibiotic Action (@TheUrgentNeed) October 11, 2019
ID Update: The American Thoracic Society and the Infectious Diseases Society of America have released updated clinical practice guidelines on the management of adult patients with community-acquired pneumonia (Am J Respir Crit Care Med 2019;200:e45). https://t.co/XdLmpv0KK3
— Sanford Guide (@sanfordguide) October 11, 2019
We say it all the time. We better get smarter and start doing a better job of protecting Mother Earth. 🌍https://t.co/Qou4eJTzHs #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) October 11, 2019
This is a good second step, but this affects very small % of drugs in US. Public health would be better served if @US_FDA would focus on restricting preventative uses of #antibiotics that mirror growth promotion doses and durations. https://t.co/1QSMnD7wan #AntibioticResistance pic.twitter.com/MUTjTX6Veh
— Battle Superbugs (@battlesuperbugs) October 11, 2019
We are almost entering the post-antibiotic era where there could be very little done to treat simple infectious diseases. https://t.co/a6GD1XUOMx
— Samreenkhn (@samreenkhn) October 11, 2019
Great paper will come in handy with residents, MS and anyone interested in ID! #WhyID : Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter | Open Forum Infectious Diseases | Oxford Academic https://t.co/r0zHDeMHn1
— Lizbeth Cahuayme (@LCahuayme) October 11, 2019
IDSA Treasurer Helen Boucher, MD, FACP, FIDSA (@hboucher3) has been named Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center (@TuftsMedicalCtr). Congratulations Dr. Boucher on your well-deserved success! 🎉https://t.co/ILRB3ohhuy pic.twitter.com/BuBoESHXgj
— IDSA (@IDSAInfo) October 11, 2019
Postdischarge oral antimicrobial use among hospitalized patients across an integrated national healthcare network.: Antimicrobial stewardship programs have focused on reducing inappropriate inpatient antimicrobial prescribing but several small studies… https://t.co/Y8DvUnzyKs
— Dentistry News (@Dentistry_bio) October 11, 2019
The "messaging" of ceftaroline has been carefully curated: 2 trials showing non-inferiority to ceftriaxone (FOCUS-1 and -2) were published in a relatively lower impact journal AFTER a combined "trial' was published in @IDSAInfo CID (doi 10.1086/657313 https://t.co/07jlgqIIlg)
— Andrew Morris (@ASPphysician) October 11, 2019
There have been claims that ceftaroline is superior to ceftriaxone for CAP, supported by 2 recent metanalyses: 1 performed by manufacturer looking at 3RCTs PORT Risk Class III-IV (doi 10.1093/jac/dkv415, https://t.co/bvBJQyPBWF) and other looking at 5 RCTs (10.3390/jcm8060824)
— Andrew Morris (@ASPphysician) October 11, 2019
Acquisition and dissemination of cephalosporin-resistant E. coli in migratory birds sampled at an Alaska landfill as inferred through genomic analysis. https://t.co/lGIqbcWf3X
— AntibioticResistance (@AntibioticResis) October 11, 2019
52% of nurses not familiar with term 'antimicrobial stewardship' https://t.co/mujhcOLkxb
— JONA Online (@JONAonline) October 11, 2019
Clinical laboratory tests used to aid in diagnosis of human prion disease: a minireview from @JClinMicro https://t.co/fl8TQ3854x#ASMClinMicro pic.twitter.com/HEsEAM4TFr
— ASM (@ASMicrobiology) October 11, 2019
Curious how the performance of antimicrobial stewardship programs (ASPs) is measured? A recent bioMérieux-sponsored webinar discussed how ASP metrics are created and the power they can have. Visit #biomerieuxconnection to learn more! https://t.co/OQWJFCfVEC
— bioMérieux Inc. (@biomerieux_inc) October 11, 2019
Not-so-good news for antibiotic developer Motif regarding their improved trimethoprim analog iclaprim...#antimicrobialresistance #amr #antibioticresistance
— Mark Blaskovich (@mark_blaskovich) October 11, 2019
The end of the road for Motif Bio - https://t.co/skB0Wh4m9s
Registration and abstracts submissions now open for the Nature Conference on Vector-borne Infectious Diseases, March 2020 #vectorborneid20
— Nicolas Fanget (@nfanget) October 11, 2019
It is a collaboration between @utmbhealth, @NatureConf, @NatureComms and @Nature_NPJ (npj Vaccines) https://t.co/RH9CoPXbEF
Genome analysis of #ClostridiumDifficile RT014 in pigs and humans suggests the infection may have a #zoonotic or #foodborne etiology. #CDifficile #Microbiology #InfectiousDiseases
— Frontiers (@FrontiersIn) October 11, 2019
Read the #openaccess research article published in @FrontMicrobiol: https://t.co/yxxpo2rPBk pic.twitter.com/DBgX6zbLa6
What a start to @UKCPA Infection network Masterclass from @DrKieranHand.
— Chris Little PhD 💊🦠 (@drcjlittle) October 11, 2019
He inspired me to become an antimicrobial pharmacist back in the day. A passionate and honest description of his amazing career, so far.#Pharmacist #UKCPA #KeepAntibioticsWorking#AntimicrobialResistance pic.twitter.com/BIBjnTAZxU
Analysis of β-tubulin-carbendazim interaction reveals that binding site for MBC fungicides does not include residues involved in fungicide resistance. https://t.co/p5Ayl0nvvG
— AntibioticResistance (@AntibioticResis) October 11, 2019
Researchers highlight serious side effects of unneeded dental antibiotics https://t.co/JrugfdHJwt
— Dan Ricciuto (@Abx_ID_Doc) October 11, 2019
Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates. https://t.co/HGg64pXKEu
— AntibioticResistance (@AntibioticResis) October 11, 2019
This is an important study. Shorter courses are preferred to longer courses for lots of reasons. This shows the shorter course is OK for Strep. https://t.co/Ui2Kjj0aIX
— Peter Collignon (@CollignonPeter) October 11, 2019
#DYK: #Tetanus is fatal in 10-12 percent of case but nearly all reported cases are in people who were never #vaccinated or who have not had a booster dose every 10 years as recommended?https://t.co/PYbkMvcFCl #GetVaccinated pic.twitter.com/Gg6iRgmHOF
— NFID (@NFIDvaccines) October 11, 2019
#DYK: Heart disease is the #1 killer in the US—for both men and women? Heart disease increases risk from #flu and related complications. Learn more at: https://t.co/ldpl7HyCk2 #GetVaccinated to #LowerYourFluRisk pic.twitter.com/9rh4cBA26q
— NFID (@NFIDvaccines) October 11, 2019
Excited for this year's #AgarArt Maker & Kids entries! If you were part of a workshop hosted by our partners, enter by 10/22 to win 💰! https://t.co/YuVE9cBafy @MicroClubNCSU @rainincubator @peshawar2o @genspacenyc @SVA_News @BosLabMA @OhloneCollege @bioriidl #DIYbio
— ASM (@ASMicrobiology) October 11, 2019
@doctorsanjay presenting how to improve paediatric Antimicrobial stewardship @UKCPAPIN Masterclass. Pharmacist can help reduce parents going to GP for antibiotics. @RakheePatel81 @DrDianeAshiru #UKCPAPIN pic.twitter.com/TAursHOaXg
— Tejal Vaghela (@tejalvaghela15) October 11, 2019
Adults with chronic health conditions are at high risk for complications from #flu. Learn what you can do to help #FightFlu at https://t.co/5OlDg1uH0Z #GetVaccinated to #LowerYourFluRisk pic.twitter.com/Z8ud3WjPiG
— NFID (@NFIDvaccines) October 11, 2019
Listening to how the @CW_Pharmacists programme is enabling UK #pharmacists to support the global fight against AMR. Great presentation including work @antibioticangel is currently doing in Uganda. I'm a little jealous 💚#antimicrobialresistance #ukcpapin #AntibioticGuardian pic.twitter.com/kUwmEai6fY
— Chris Little PhD 💊🦠 (@drcjlittle) October 11, 2019
Those #Probiotics May Actually Be Hurting Your ‘Gut Health’.
— Microbes&Infection (@MicrobesInfect) October 11, 2019
In the next 10 years, global sales are forecast to nearly double. But most recent research suggests that over-the-counter #probiotic supplements could have a detrimental effect.https://t.co/Qx4K7NBxgX #microbiota pic.twitter.com/tbkMuIxpsW
Oh me too! That’s 1 major damage of guidelines. It’s exacerbated in ID because ID may be only field where a drug being safe/effective for the target dz is NOT enough for it to be appropriate to use. Stewardship principles should be baked into all guidelines. Sadly they aren’t.
— Brad Spellberg (@BradSpellberg) October 11, 2019
New data from @CDCgov reveals a large number of pregnant women are not receiving two critical vaccines, the Tdap and the influenza vaccine. https://t.co/8oA9TPynp2 #VaccinesWork
— IDSA (@IDSAInfo) October 11, 2019
Perusing the great "Breakpoints" podcast series from @SIDPharm (https://t.co/oRtdv7Suzl):
— Mike Stevens (@Dr_Mike_Stevens) October 11, 2019
Wondering if there are plans for an #IDWeek2019 highlights episode?
Or from the upcoming @SHEA_Epi & @CDCgov Decennial conference? (https://t.co/derOcA5PYW) @ErinMcCreary #ECCMID2019
We are busting #flu myths with Dr. Zane Saul – Chief of Infectious Diseases at Bridgeport Hospital. https://t.co/pF7mwvhecB
— WTNH News 8 (@WTNH) October 11, 2019
Whether he is focused on identifying a potential therapy or studying pathogens in nature, KGI Professor Mikhail Martchenko is dedicated to treating infectious diseases. 📲 Read more: https://t.co/ZlaSK5OwJC pic.twitter.com/3T7ckUmyLC
— Keck Graduate Inst (@KeckGrad) October 11, 2019
A fantastic presentation by @LauraWhitney123 on AF stewardship. Some great tips on implementing a stewardship programme @MGilchrist123 @UKCPAPIN #antifungalstewardship #UKCPA #PINmasterclass pic.twitter.com/6BoOnagc1g
— Aneeka Chavda (@aneeka_chavda) October 11, 2019
@MartinLlewelyn On @ARK_Hospital - Do we worry about the harm that antibiotics can cause when patients are left on these over the weekend without a review! #UKCPAPIN #AntimicrobialStewardship #Antimicrobialresistance #antibioticguardian @AntibioticLeeds @LTHTAntibiotics
— Abimbola Olusoga (@Abimbola_pharm) October 11, 2019
Antibiotic use in farming for anything other than actual infections simply has to stop. Antimicrobial stewardship is everyone’s business. https://t.co/EjzH3QHkvD
— Paul Morgan (@drpaulmorgan) October 11, 2019
Yesterday on @moneyfm893: Prof Ooi Eng Eong, Deputy Director, Emerging Infectious Diseases Programme, @dukenus, spoke about the existence of flu and how its associated risks are best managed in our society.#DukeNUS #EmergingInfectiousDiseases #Flu
— Duke-NUS (@dukenus) October 11, 2019
▶️ https://t.co/deyv3gAWzO
But its more that PK/PD is a continuum and higher exposures relative to the MIC has shown to impact other (not yes/no) outcomes. And there is at the very least a suggestion that this is occurring with ceftaroline vs CRO in CAP https://t.co/IrBGSVJOx5
— Jason Pogue (@jpogue1) October 11, 2019
A must read: “New drugs against CRE address a major, previously unmet medical need and are critical to save lives. If the market can’t support them, then that is a chilling commentary on the future of antibiotic development." https://t.co/Lu0jPdJ1ZW
— Battle Superbugs (@battlesuperbugs) October 11, 2019
Sign up for the AHRQ Safety Ambulatory Program for Improving Antibiotic Use.
— Jeff Linder (@jeffreylinder) October 11, 2019
Improve prescribing, communication, and efficiency in your primary or urgent care practice. MOC, CME, MIPS, Joint Commission benefits
Starts December 2019. Spots going fast...https://t.co/nrEG0cGA8a pic.twitter.com/6VSOmpjyyV
https://t.co/BIOKN28Zxm
— In the Name of Jesus (@Sheltieman3) October 11, 2019
Emerging infectious diseases from the CDC:
7 For nation shall rise against nation, and kingdom against kingdom: and there shall be famines, and pestilences, and earthquakes, in divers places.
Matthew 24:7
“There is no reporting for other medical procedures, other than reporting for infectious diseases to control outbreaks." https://t.co/i5hz494gyM
— FeministsWithoutReligion (@Womenwthoutrlgn) October 11, 2019
Created by Cameron Forbes. Last updated October 15, 2019 at 05:13 EST.